Literature DB >> 31864708

The molecular mechanism of muscle dysfunction associated with the R133W mutation in Tpm2.2.

Yurii S Borovikov1, Olga E Karpicheva2, Stanislava V Avrova2, Armen O Simonyan2, Vladimir V Sirenko2, Charles S Redwood3.   

Abstract

Ghost muscle fibres reconstituted with myosin heads labeled with the fluorescent probe 1,5-IAEDANS were used for analysis of muscle fibre dysfunction associated with the R133W mutation in β-tropomyosin (Tpm2.2). By using polarized microscopy, we showed that at high Ca2+ the R133W mutation in both αβ-Tpm heterodimers and ββ-Tpm homodimers decreases the amount of the myosin heads strongly bound to F-actin and the number of switched-on actin monomers, with this effect being stronger for ββ-Tpm. This mutation also inhibits the shifting of the R133W-Tpm strands towards the open position and the efficiency of the cross-bridge work. At low Ca2+, the amount of the strongly bound myosin heads is lower for R133W-Tpms than for WT-Tpms which may contribute to a low myofilament Ca2+-sensitivity of the R133W-Tpms. It is concluded that freezing of the mutant αβ- or ββ-Tpm close to the blocked position inhibits the strong binding of the cross-bridges and the switching on of actin monomers which may be the reason for muscle weakness associated with the R133W mutation in β-tropomyosin. The use of reagents that activate myosin may be appropriate to restore muscle function in patients with the R133W mutation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Molecular mechanisms; Muscle contraction regulation; Muscle fibre; Nemaline myopathy; Tropomyosin mutation

Mesh:

Substances:

Year:  2019        PMID: 31864708     DOI: 10.1016/j.bbrc.2019.12.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.

Authors:  Yurii S Borovikov; Armen O Simonyan; Stanislava V Avrova; Vladimir V Sirenko; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

2.  Looking for Targets to Restore the Contractile Function in Congenital Myopathy Caused by Gln147Pro Tropomyosin.

Authors:  Olga E Karpicheva; Armen O Simonyan; Nikita A Rysev; Charles S Redwood; Yurii S Borovikov
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

Review 3.  Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.

Authors:  Daniela Rossi; Maria Rosaria Catallo; Enrico Pierantozzi; Vincenzo Sorrentino
Journal:  J Gen Physiol       Date:  2022-08-18       Impact factor: 4.000

4.  A pathogenic mechanism associated with myopathies and structural birth defects involves TPM2-directed myogenesis.

Authors:  Jennifer McAdow; Shuo Yang; Tiffany Ou; Gary Huang; Matthew B Dobbs; Christina A Gurnett; Michael J Greenberg; Aaron N Johnson
Journal:  JCI Insight       Date:  2022-06-22

5.  Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.

Authors:  Yurii S Borovikov; Daria D Andreeva; Stanislava V Avrova; Vladimir V Sirenko; Armen O Simonyan; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.